Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields

Acta Oncologica

Volumn 41, Issue 6, 2002, Pages 532-542

  Al Abany, Massoud ^a   Helgason, Ásgeir R ^a,b   Ågren Cronqvist, Anna Karin ^c   Svensson, Christer ^d   Wersäll, Peter ^d   Steineck, Gunnar ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b City of Stockholm   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LIGHT; OPTICAL COLLIMATORS; TUMORS;

LOCALIZED PROSTATE CANCER;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL FEATURE; COLLIMATOR; CONTROLLED STUDY; DEFECATION; DIARRHEA; DISTRESS SYNDROME; FECES ANALYSIS; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MICTURITION; PRIORITY JOURNAL; PROSTATE CARCINOMA; QUESTIONNAIRE; RADIATION FIELD; RISK ASSESSMENT; SEXUAL FUNCTION; STATISTICAL SIGNIFICANCE; SWEDEN;

EID: 0036942849     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860214963     Document Type: Article

References (33)

1. Michalski JM, Purdy JA, Winter K, et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 2000; 46: 391-602.
2. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet 1999; 353 (9149): 267-72.
3. al Abany M, Steineck G, Ågren Cronqvist AK, Helgason AR. Improving the preservation of erectile function after external beam radiation therapy for prostate cancer. Radiother Oncol 2000; 57: 201-6.
4. Leibel SA, Ling CC, Kutcher GJ, et al. The biological basis of conformal three-dimensional radiation therapy. Int Radiat Oncol Biol Phys 1991; 21: 805-11.
5. Leibel SA, Kutcher GJ, Mohan R, Burman CM, Kelson S, Fuks Z. Three-dimensional conformal radiation therapy at Memorial Sloan Kettering Cancer Center. Semin in Radiat Oncol 1992; 2: 274-89.
6. Lichter AS. Three-dimensional conformal radiation therapy: A testable hypothesis. Int J Radiat Oncol Biol Phys 1991; 21: 853-65.
7. Redpath AT, Williams JR, Thwaites DI. Treatment planning of external beam therapy. In: Williams JR, Thwaites DI, eds. Radiotherapy Physics in Practice. Oxford, NY, Tokyo: Oxford University Press, 1993: 135-85.
8. Webb S. The Physics of Three-dimensional Radiation Therapy, Conformal Radiotherapy, Radiosurgery and Treatment Planning, 1st Ed. London: IOP Publishing Ltd, 1993.
9. Steineck G, Bergmark K, Henningsohn L, al-Abany M, Dickman P, Helgason AR. Symptom documentation in cancer survivors as a basis for therapy modification. Acta Oncol 2002; 41: 244-52.
10. Helgason AR, Arver S, Adolfsson J, Dickman P, Granath F, Steineck G. 'Potency': The validation of information from a self-administered questionnaire using objective measurements of night-time erections and test-retest reliability. Br J Urol 1998; 81: 135-41.
11. Bergmark K, Avall-Lundqvist E, Dickman P, Henningsohn L, Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 1999; 340: 1383-9.
12. Rothman KJ, Greenland S, eds. Modern Epidemiology. 2nd Ed. Philadelphia: Lippincott-Raven Publishers, 1998: 271.
13. SAS Procedures Guide, Version 6. 3rd Ed. Cary, NC: SAS Institute, 1990: 350.
14. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU Report 50. Bethesda: ICRU, 1993.
15. Niemierko A, Goitein M. Modeling of normal tissue response to radiation: The critical volume model. Int J Radiother Oncol Biol Phys 1993; 25: 135-45.
16. Tubiana D, Dutreix J, Wambersie A. Effects on normal tissues. In: Tubiana D, Dutreix J, Wambersie A, eds. Introduction to Radiobiology, 1st Edition. London: Taylor and Francis Ltd, 1990: 126-73.
17. Jackson A, Skwarchuk M W, Zelefsky M J, et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 1991; 49: 685-98.
18. Adolfsson J, Helgason AR, Dickman P, Steineck G. Urinary and bowel symptoms in men with and without prostate cancer: Results from an observational study in the in the Stocholm area. Eur Urol 1998; 33: 11-6.
19. Henningsohn L, Wijkström Bergmark HK, Dickman P, Bergmark K, Steineck G. Distressful symptoms after radical cystectomy with urinary diversion for urinary bladder cancer: A Swedish population-based study. Eur Urol 2001; 249: 1-12.
20. Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 1994; 74: 2520-32.
21. Lilleby W, Fosså SD, Waehre HR, Olsen DR. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 1999; 43: 735-43.
22. Nguyen LN, Pollack A, Zagars GK. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: Results of a self-assessment questionnaire. Urology 1997; 51: 991-7.
23. Crook J, Esche B, Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: The patient's perspective. Urology 1996; 47: 387-94.
24. Helgason ÁR, Fredrikson M, Adolfsson J, Steineck G. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int Radiat Oncol Biol Phys 1995; 32: 33-9.
25. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
26. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM. Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE: Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1999; 54: 503-8.
27. Mantz CA, Vokes EE, Stenson K, et al. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer. Cancer J 1997; 54: 551-7.
28. Shipley WU, Zietman AL, Hanks GE, et al. Treatment related sequelae following external beam radiation for prostate cancer: A review with an update in patients with stages T1 and T2 tumor. J Urol 1994; 152: 1799-805.
29. Hanley J, Lumley MA, Mageras GS, et al. Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 1997; 37: 435-44.
30. Lebesque JV, Bruce AM, Kroes AP, Touw A, Shouman RT, van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 1995; 33: 1109-19.
31. Melian E, Mageras GS, Fuks Z, et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys 1997; 38: 73-81.
32. Roeske JC, Forman JD, Mesina CF, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995; 33: 1321-9.
33. Whitmore WF, Adolfsson J, Steineck G. Conservative management of localized prostatic cancer. Am J Clin Oncol 1992; 15: 446-52.